Peter Mcl. Black

Q: What Schools Are Affiliated With Peter Mcl. Black

Peter Mcl. Black is affiliated with the following schools: University of British Columbia, Kiel University, Massachusetts Institute of Technology, Massachusetts General Hospital

Peter Mcl. Black's AcademicInfluence.com Rankings

Peter Mcl. Black

Biology

#6140

World Rank

#8790

Historical Rank

Neuroscience

#729

World Rank

#761

Historical Rank

biology Degrees

Download Badge

Biology

Peter Mcl. Black's Degrees

PhD Neuroscience University of California, San Francisco
Bachelors Biology Stanford University

Similar Degrees You Can Earn

Best Online Bachelor's in Biology 2026

Why Is Peter Mcl. Black Influential?

(Suggest an Edit or Addition)

(See a Problem?)

Peter Mcl. Black's Published Works

Number of citations in a given year to any of this author's works

Total number of citations to an author for the works they published in a given year. This highlights publication of the most important work(s) by the author

Published Works

Neural stem cells display extensive tropism for pathology in adult brain: evidence from intracranial gliomas. (2000) (1198)
Gene expression-based classification of malignant gliomas correlates better with survival than histological classification. (2003) (952)
Diagnosing Idiopathic Normal-pressure Hydrocephalus (2005) (849)
Development and implementation of intraoperative magnetic resonance imaging and its neurosurgical applications. (1997) (783)
Long-term mortality after transsphenoidal surgery and adjunctive therapy for acromegaly. (1998) (652)
Epidemiology of intracranial meningioma. (2005) (634)
Stereotactic radiosurgery for the definitive, noninvasive treatment of brain metastases. (1995) (585)
Cellular-telephone use and brain tumors. (2001) (503)
Microvessel density is a prognostic indicator for patients with astroglial brain tumors (1996) (500)
Transcranial Magnetic Resonance Imaging– Guided Focused Ultrasound Surgery of Brain Tumors: Initial Findings in 3 Patients (2010) (470)
Automated segmentation of MR images of brain tumors. (2001) (456)
Phase II trial of the antiangiogenic agent thalidomide in patients with recurrent high-grade gliomas. (2000) (420)
The Value of Supplemental Prognostic Tests for the Preoperative Assessment of Idiopathic Normal-pressure Hydrocephalus (2005) (401)
Somatic Activation of AKT3 Causes Hemispheric Developmental Brain Malformations (2012) (396)
Continuous release of endostatin from microencapsulated engineered cells for tumor therapy (2001) (366)
The prognostic significance of phosphatidylinositol 3-kinase pathway activation in human gliomas. (2004) (363)
Incidence and management of complications of transsphenoidal operation for pituitary adenomas. (1987) (354)
Intracranial inhibition of platelet-derived growth factor-mediated glioblastoma cell growth by an orally active kinase inhibitor of the 2-phenylaminopyrimidine class. (2000) (328)
Delayed cerebral vasospasm is not reversible by aminophylline, nifedipine, or papaverine in a "two-hemorrhage" canine model. (1983) (324)
αvβ3 and αvβ5 Integrin Expression in Glioma Periphery (2001) (312)
Comparison of stereotactic radiosurgery and brachytherapy in the treatment of recurrent glioblastoma multiforme. (1995) (293)
Scale to predict survival after surgery for recurrent glioblastoma multiforme. (2010) (291)
Expression of cyclooxygenase 2 (COX-2) in human glioma and in vitro inhibition by a specific COX-2 inhibitor, NS-398. (2000) (282)
Idiopathic normal-pressure hydrocephalus. Results of shunting in 62 patients. (1980) (278)
Quantitatively determined survivin expression levels are of prognostic value in human gliomas. (2002) (268)
Radiosurgery as part of the initial management of patients with malignant gliomas. (1992) (251)
Growth Factors in Glioma Angiogenesis: FGFs, PDGF, EGF, and TGFs (2000) (246)
Serial registration of intraoperative MR images of the brain (2002) (234)
Microvessel count and cerebrospinal fluid basic fibroblast growth factor in children with brain tumours (1994) (232)
Computer-assisted interactive three-dimensional planning for neurosurgical procedures. (1996) (225)
Surgical Management of Idiopathic Normal-pressure Hydrocephalus (2005) (221)
Treatment of patients with primary glioblastoma multiforme with standard postoperative radiotherapy and radiosurgical boost: prognostic factors and long-term outcome. (1999) (220)
Marked genomic differences characterize primary and secondary glioblastoma subtypes and identify two distinct molecular and clinical secondary glioblastoma entities. (2006) (216)
The prognostic significance of postoperative residual tumor in ependymoma. (1991) (213)
Temozolomide-Mediated Radiation Enhancement in Glioblastoma: A Report on Underlying Mechanisms (2006) (208)
Age-related changes in intracranial compartment volumes in normal adults assessed by magnetic resonance imaging. (1996) (208)
Adult Medulloblastoma: Prognostic Factors and Patterns of Relapse (2000) (207)
Brain tumor tropism of transplanted human neural stem cells is induced by vascular endothelial growth factor. (2005) (205)
Human Neural Stem Cells Target Experimental Intracranial Medulloblastoma and Deliver a Therapeutic Gene Leading to Tumor Regression (2006) (200)
Angiostatin suppresses malignant glioma growth in vivo. (1998) (199)
Low-dose chemotherapy combined with an antiangiogenic drug reduces human glioma growth in vivo. (2001) (197)
Initial clinical results of LINAC-based stereotactic radiosurgery and stereotactic radiotherapy for pituitary adenomas. (1998) (193)
Low rate of venous thromboembolism after craniotomy for brain tumor using multimodality prophylaxis. (2002) (191)
Cortical mapping for defining the limits of tumor resection. (1987) (190)
Non-rigid alignment of pre-operative MRI, fMRI, and DT-MRI with intra-operative MRI for enhanced visualization and navigation in image-guided neurosurgery (2007) (184)
Alpha(v)beta3 and alpha(v)beta5 integrin expression in glioma periphery. (2001) (179)
Intraoperative MR imaging guidance for intracranial neurosurgery: experience with the first 200 cases. (1999) (179)
Coexpression of platelet-derived growth factor (PDGF) and PDGF-receptor genes by primary human astrocytomas may contribute to their development and maintenance. (1990) (179)
Intravascular delivery of neural stem cell lines to target intracranial and extracranial tumors of neural and non-neural origin. (2003) (178)
Expression of structural proteins and angiogenic factors in cerebrovascular anomalies. (2000) (177)
L-arginine normalizes endothelial function in cerebral vessels from hypercholesterolemic rabbits. (1991) (174)
Outcome of Shunting in Idiopathic Normal-pressure Hydrocephalus and the Value of Outcome Assessment in Shunted Patients (2005) (173)
Cerebral arterial constriction after experimental subarachnoid hemorrhage is associated with blood components within the arterial wall. (1983) (171)
Craniotomy for tumor treatment in an intraoperative magnetic resonance imaging unit. (1999) (171)
Hydrocephalus and vasospasm after subarachnoid hemorrhage from ruptured intracranial aneurysms. (1986) (166)
Development of Guidelines for Idiopathic Normal-pressure Hydrocephalus: Introduction (2005) (166)
Loss of distinct regions on the short arm of chromosome 17 associated with tumorigenesis of human astrocytomas. (1989) (164)
Complications of therapy for venous thromboembolic disease in patients with brain tumors (1993) (160)
Phase II Study of Protracted Daily Temozolomide for Low-Grade Gliomas in Adults (2009) (158)
MEDICAL PROGRESS : BRAIN TUMORS (SECOND OF TWO PARTS) (1991) (157)
Clinical patterns of failure following stereotactic interstitial irradiation for malignant gliomas. (1990) (157)
Cerebrospinal fluid may nourish cerebral vessels through pathways in the adventitia that may be analogous to systemic vasa vasorum. (1982) (154)
Hormone production in clinically nonfunctioning pituitary adenomas. (1987) (152)
In vitro and In vivo Activity of the Nuclear Factor-κB Inhibitor Sulfasalazine in Human Glioblastomas (2004) (151)
The value of multichannel MEG and EEG in the presurgical evaluation of 70 epilepsy patients (2006) (150)
SNAI2/Slug promotes growth and invasion in human gliomas (2010) (148)
Targeting of melanoma brain metastases using engineered neural stem/progenitor cells. (2006) (147)
Glycoprotein hormone genes are expressed in clinically nonfunctioning pituitary adenomas. (1987) (147)
PEX-Producing Human Neural Stem Cells Inhibit Tumor Growth in a Mouse Glioma Model (2005) (143)
Magnetic resonance imaging therapy. Intraoperative MR imaging. (1996) (139)
Patient tolerance of craniotomy performed with the patient under local anesthesia and monitored conscious sedation. (1998) (134)
CSF shunts for dementia, incontinence, and gait disturbance. (1985) (129)
DNA repair gene polymorphisms and risk of adult meningioma, glioma, and acoustic neuroma. (2010) (128)
Thallium-201 versus technetium-99m-MIBI SPECT in evaluation of childhood brain tumors: a within-subject comparison. (1993) (127)
Phase II study of metronomic chemotherapy for recurrent malignant gliomas in adults. (2007) (126)
Quantification of microheterogeneity in glioblastoma multiforme with ex vivo high-resolution magic-angle spinning (HRMAS) proton magnetic resonance spectroscopy. (2000) (125)
Simultaneous inhibition of glioma angiogenesis, cell proliferation, and invasion by a naturally occurring fragment of human metalloproteinase-2. (2001) (125)
Suppression of false recognition in Alzheimer's disease and in patients with frontal lobe lesions. (2002) (121)
Automated Segmentation of MRI of Brain Tumors (2001) (120)
Targeting Rat Brainstem Glioma Using Human Neural Stem Cells and Human Mesenchymal Stem Cells (2009) (119)
Craniotomy Under Local Anesthesia and Monitored Conscious Sedation for the Resection of Tumors Involving Eloquent Cortex (2000) (118)
Experimental normal-pressure hydrocephalus is accompanied by increased transmantle pressure. (1984) (117)
Long term results of stereotactic brachytherapy used in the initial treatment of patients with glioblastomas (1994) (117)
Fractionated stereotactic radiotherapy for the treatment of acoustic neuromas: preliminary results. (1996) (114)
Computer-assisted Interactive Three-dimensional Planning Neurosurgical Procedures (1996) (114)
Results of linear accelerator-based radiosurgery for intracranial meningiomas. (1998) (113)
A genome-wide screen reveals functional gene clusters in the cancer genome and identifies EphA2 as a mitogen in glioblastoma. (2006) (113)
Prognostic and pathologic significance of quantitative protein expression profiling in human gliomas. (2001) (113)
Stereotactic radiotherapy for pediatric and adult brain tumors: preliminary report. (1994) (111)
Biochemical characterization of pediatric brain tumors by using in vivo and ex vivo magnetic resonance spectroscopy. (2002) (111)
Stereotactic Radiotherapy for Vestibular Schwannomas: Favorable Outcome with Minimal Toxicity (2005) (111)
Image-guided surgery. (1999) (110)
Segmentation of Meningiomas and Low Grade Gliomas in MRI (1999) (109)
Frameless Stereotactic Neurosurgery Using Intraoperative Magnetic Resonance Imaging: Stereotactic Brain Biopsy (2000) (106)
Genomic Profiling Reveals Alternative Genetic Pathways of Meningioma Malignant Progression Dependent on the Underlying NF2 Status (2010) (103)
Oxidative response gene polymorphisms and risk of adult brain tumors. (2008) (101)
Intra‐operative MR guidance during trans‐sphenoidal pituitary resection: Preliminary results (2001) (101)
Polymorphisms in Apoptosis and Cell Cycle Control Genes and Risk of Brain Tumors in Adults (2007) (100)
Intra-operative magnetic resonance imaging in neurosurgery (2004) (100)
The use of the Codman-Medos Programmable Hakim valve in the management of patients with hydrocephalus: illustrative cases. (1994) (99)
Sociodemographic indicators and risk of brain tumours. (2003) (97)
Transsphenoidal Resection of Pituitary Adenomas in an Intraoperative MRI Unit (1999) (96)
Three-Dimensional Optical Flow Method for Measurement of Volumetric Brain Deformation from Intraoperative MR Images (2000) (92)
Use of subdural grids and strip electrodes to identify a seizure focus in children. (1995) (90)
Neuroimaging in pediatric brain tumors: Gd-DTPA-enhanced, hemodynamic, and diffusion MR imaging compared with MR spectroscopic imaging. (2002) (90)
Supratentorial low-grade glioma resectability: statistical predictive analysis based on anatomic MR features and tumor characteristics. (2006) (89)
Deep vein thrombosis and pulmonary emboli in neurosurgical patients: a review. (1984) (89)
Expression and activation of epidermal growth factor receptors in meningiomas. (1997) (88)
Capturing intraoperative deformations: research experience at Brigham and Women's hospital (2005) (87)
SURGERY FOR CONVEXITY MENINGIOMAS (2008) (86)
Phase II study of temozolomide, thalidomide, and celecoxib for newly diagnosed glioblastoma in adults. (2008) (86)
Glioma-produced extracellular matrix influences brain tumor tropism of human neural stem cells (2006) (85)
Genetic polymorphisms in GSTM1, -P1, -T1, and CYP2E1 and the risk of adult brain tumors. (2003) (85)
Vascular endothelial growth factor-stimulated cerebral microvascular endothelial cells mediate the recruitment of neural stem cells to the neurovascular niche (2009) (84)
Sir Victor Horsley (1857-1916): pioneer of neurological surgery. (2002) (83)
Lymphocytic adenohypophysitis of pregnancy with complete recovery. (1987) (81)
Retinoids inhibit human glioma cell proliferation and migration in primary cell cultures but not in established cell lines. (2000) (81)
Nephron-sparing surgery of renal cell carcinoma with a normal opposite kidney: long-term outcome in 180 patients. (2000) (80)
Lead, Genetic Susceptibility, and Risk of Adult Brain Tumors (2006) (80)
Expression of Estrogen Receptors Alpha and Beta in Human Meningiomas (1999) (79)
Video registration virtual reality for nonlinkage stereotactic surgery. (1994) (79)
Linac Radiosurgery for Skull Base Meningiomas (2001) (76)
Angiogenesis in Brain Tumors (2013) (75)
The present and future role of intraoperative MRI in neurosurgical procedures. (1997) (73)
The Neurosurgeon as Local Oncologist: Cellular and Molecular Neurosurgery in Malignant Glioma Therapy (2003) (72)
Results of radiosurgery in the management of recurrent and residual medulloblastoma. (1995) (72)
Aggressive Surgery and Focal Radiation in the Management of Meningiomas of the Skull Base: Preservation of Function with Maintenance of Local Control (2001) (72)
Secretory tumors of the pituitary gland (1984) (70)
Occupation and the risk of adult glioma in the United States (2003) (70)
Detection of activated platelet-derived growth factor receptors in human meningioma. (1997) (70)
Experience with external pneumatic calf compression in neurology and neurosurgery. (1986) (70)
Clinical Experience with a Hich Precision Image-Guided Neurosurgery System (1998) (70)
Specific genes expressed in association with progesterone receptors in meningioma. (2008) (70)
Multiparametric MR assessment of pediatric brain tumors (2002) (70)
Neural stem cell biology may be well suited for improving brain tumor therapies. (2003) (69)
External pneumatic calf compression reduces deep venous thrombosis in patients with ruptured intracranial aneurysms. (1986) (69)
Intracranial compartment volumes in patients with enlarged ventricles assessed by magnetic resonance-based image processing. (1996) (68)
TECHNIQUES AND COMPLICATIONS OF EXTERNAL LUMBAR DRAINAGE FOR NORMAL PRESSURE HYDROCEPHALUS (2008) (66)
Comparative effectiveness of frame-based, frameless, and intraoperative magnetic resonance imaging-guided brain biopsy techniques. (2015) (65)
Management of large pituitary adenomas by transsphenoidal surgery. (1988) (65)
Diffusion Tensor and Functional MRI Fusion with Anatomical MRI for Image-Guided Neurosurgery (2003) (64)
Meningiomas: Updating Basic Science, Management, and Outcome (2004) (64)
Radiosurgery in the management of pediatric brain tumors. (2001) (63)
Quality of Life Following Surgery for Intracranial Meningiomas at Brigham and Women's Hosipital: A Study of 164 Patients Using a Modification of the Functional Assessment of Cancer Therapy–brain Questionnaire (2000) (62)
A prospective randomized pilot study evaluating an ERAS protocol versus a standard protocol for patients treated with radical cystectomy and urinary diversion for bladder cancer (2018) (62)
Luteinizing hormone-secreting pituitary tumor: biosynthetic characterization and clinical studies. (1987) (61)
Aberrant splicing of cyclin-dependent kinase-associated protein phosphatase KAP increases proliferation and migration in glioblastoma. (2007) (60)
Nephron sparing surgery for central renal tumors: experience with 33 cases. (2000) (60)
Functional identification of the primary motor area by corticospinal tractography. (2005) (60)
Local checkpoint inhibition of CTLA‐4 as a monotherapy or in combination with anti‐PD1 prevents the growth of murine bladder cancer (2017) (60)
Systemic Metastasis in Glioblastoma May Represent the Emergence of Neoplastic Subclones (2000) (59)
Predicting survival of children with CNS tumors using proton magnetic resonance spectroscopic imaging biomarkers. (2007) (58)
Anti-angiogenic Treatment Strategies for Malignant Brain Tumors (2000) (57)
Continuous intracranial administration of suberoylanilide hydroxamic acid (SAHA) inhibits tumor growth in an orthotopic glioma model (2007) (57)
Use of cortical surface vessel registration for image-guided neurosurgery. (1997) (57)
Specific uptake of the auger electron-emitting thymidine analogue 5-[123I/125I]iodo-2'-deoxyuridine in rat brain tumors: diagnostic and therapeutic implications in humans. (1990) (55)
Morphological changes of the basilar artery, ventricles, and choroid plexus after experimental SAH. (1984) (55)
Image-guided Craniotomy for Cerebral Metastases: Techniques and Outcomes (2003) (54)
Toward Real-Time Image Guided Neurosurgery Using Distributed and Grid Computing (2006) (54)
Estrogen increases galanin immunoreactivity in hyperplastic prolactin-secreting cells in Fisher 344 rats. (1990) (54)
Intra-operative MRI (iop-MR) for brain tumour surgery (2009) (53)
Angiogenesis, Metastasis, and Endogenous Inhibition (2000) (53)
Interventional and intraoperative magnetic resonance imaging. (2000) (53)
Beta-endorphin and somatostatin concentrations in the ventricular cerebrospinal fluid of patients with affective disorder (1986) (52)
The 1p-encoded protein stathmin and resistance of malignant gliomas to nitrosoureas. (2007) (52)
Human cerebrospinal fluid somatostatin in neurologic disease (1985) (51)
Adjuvant chemotherapy for upper-tract urothelial carcinoma treated with nephroureterectomy: assessment of adequate renal function and influence on outcome. (2014) (51)
Surgery for extra-axial tumors of the cerebral convexity and midline. (2008) (51)
Proton magnetic spectroscopic imaging of the child's brain: the response of tumors to treatment (2001) (51)
Use of Cortical Surface Vessel Registration for Image-guided Neurosurgery. (1997) (50)
Risk factors for bladder cancer recurrence after nephroureterectomy for upper tract urothelial tumors: results from the Canadian Upper Tract Collaboration. (2014) (50)
Transcranial MRI-guided focused ultrasound surgery of brain tumors: Initial findings in patients (2008) (50)
The contemporary role of lymph node dissection during nephroureterectomy in the management of upper urinary tract urothelial carcinoma: the Canadian experience. (2011) (50)
5-[125I]iodo-2'-deoxyuridine in the radiotherapy of brain tumors in rats. (1998) (49)
Harvey Cushing at the Peter Bent Brigham Hospital. (1999) (49)
Dual-isotope single-photon emission computerized tomography scanning in patients with glioblastoma multiforme: association with patient survival and histopathological characteristics of tumor after high-dose radiotherapy. (1998) (49)
Origins of intraoperative MRI. (2010) (48)
Local Delivery of Poly Lactic-co-glycolic Acid Microspheres Containing Imatinib Mesylate Inhibits Intracranial Xenograft Glioma Growth (2009) (48)
Optimizing intravesical mitomycin C therapy in non-muscle-invasive bladder cancer (2014) (48)
Cerebral edema in intracranial meningiomas: evidence for local and diffuse patterns and factors associated with its occurrence. (1994) (47)
Statistical validation of brain tumor shape approximation via spherical harmonics for image-guided neurosurgery. (2005) (47)
Comparison of oncological outcomes for open and laparoscopic radical nephroureterectomy: results from the Canadian Upper Tract Collaboration (2013) (47)
Matrix solution fixation: histology-compatible tissue preparation for MALDI mass spectrometry imaging. (2007) (46)
Surgical Resection for Patients with Solid Brain Metastases: Current Status (2004) (45)
Cerebrospinal Fluid Biomarkers in Idiopathic Normal Pressure Hydrocephalus (2011) (45)
Season of birth and risk of brain tumors in adults (2004) (44)
A low-field intraoperative MRI system for glioma surgery: is it worthwhile? (2005) (44)
αvβ3 and αvβ5 Integrin expression in meningiomas (2000) (44)
Image-guided neurosurgery at Brigham and Women's Hospital (2006) (43)
Intraoperative magnetic resonance imaging: considerations for the operating room of the future (2001) (43)
GM3 as a Novel Growth Regulator for Human Gliomas (2001) (43)
High-grade astrocytomas. (1995) (43)
Occupational exposure to magnetic fields and the risk of brain tumors. (2009) (43)
Asymmetrical hydrocephalus following ventriculitis from rupture of a thalamic abscess. (1983) (43)
Imaging of meningioma progression by matrix-assisted laser desorption ionization time-of-flight mass spectrometry. (2010) (43)
Metastasis and angiogenesis. (2004) (43)
The Use of a Simple Likert Scale to Measure Quality Of Life In Brain Tumor Patients (2001) (42)
Advances in radiation therapy for craniopharyngiomas. (1994) (42)
Management of small cell carcinoma of the bladder: Consensus guidelines from the Canadian Association of Genitourinary Medical Oncologists (CAGMO). (2013) (42)
Long-Term Follow-Up of Patients Treated with Stereotactic Radiosurgery for Single or Multiple Brain Metastases1 (1996) (40)
Correlation between lumbo-ventricular perfusion and MRI-CSF flow studies in idiopathic normal pressure hydrocephalus. (1998) (40)
The neurobiology of normal pressure hydrocephalus. (1993) (40)
Stereotactic craniotomy: methods and results using the Brown-Roberts-Wells stereotactic frame. (1989) (40)
Management of symptomatic deep venous thrombosis and pulmonary embolism on a neurosurgical service. (1986) (39)
Multifocality rather than tumor location is a prognostic factor in upper tract urothelial carcinoma. (2013) (38)
Permanent low-activity iodine-125 implants for cerebral metastases (1997) (38)
Immediate titanium mesh cranioplasty for treatment of postcraniotomy infections. (2013) (37)
Surgical navigation in the open MRI. (2003) (37)
Cerebrospinal fluid dynamics and hydrocephalus after experimental subarachnoid hemorrhage. (1985) (37)
Origins of intraoperative MRI. (2009) (37)
Novel local drug delivery system using thermoreversible gel in combination with polymeric microspheres or liposomes. (2010) (36)
Self-reported electrical appliance use and risk of adult brain tumors. (2005) (36)
Declaration of brain death in neurosurgical and neurological practice. (1984) (36)
Dopaminergic Regulation of a-Subunit Secretion and Messenger Ribonucleic Acid Levels in a-Secreting Pituitary Tumors* (1988) (36)
The natural history of renal function after surgical management of renal cell carcinoma: Results from the Canadian Kidney Cancer Information System. (2016) (35)
IS20I, a specific alphavbeta3 integrin inhibitor, reduces glioma growth in vivo. (2003) (34)
Clinical characteristics of complex partial seizures: a temporal versus a frontal lobe onset (1997) (34)
201Tl/99mTc-HMPAO SPECT imaging of treated childhood brain tumors. (1991) (34)
Genetic Aberrations in Human Brain Tumors (1994) (34)
Solitary brain metastases. Radiation, resection, or radiosurgery? (1993) (34)
Neurosurgery in pregnancy. (2007) (34)
Variation in genes relevant to aromatic hydrocarbon metabolism and the risk of adult brain tumors. (2006) (34)
Surgical treatment of low-grade gliomas in the intraoperative magnetic resonance imager. (1998) (34)
The Use of the Codman-Medos Programmable Hakim Valve in the Management of Patients with Hydrocephalus (1994) (33)
Intratumoral administration of 5-[123I]iodo-2'-deoxyuridine in a patient with a brain tumor. (1996) (33)
Stereotactic radiotherapy: a technique for dose optimization and escalation for intracranial tumors. (1994) (33)
Subdural mass lesion secondary to sarcoid granuloma MR and CT findings and differential diagnosis. (1989) (32)
Cancer in first-degree relatives and risk of glioma in adults. (2003) (32)
Tension pneumocephalus of the cranial subdural space: a case report. (1979) (32)
Occupation and risk of meningioma and acoustic neuroma in the United States. (2004) (32)
Intraoperative Segmentation and Nonrigid Registration for Image Guided Therapy (2000) (32)
Monitoring slowly evolving tumors (2008) (32)
The impact of method of distal ureter management during radical nephroureterectomy on tumour recurrence. (2014) (32)
Surgical Treatment of Interstitial Cystitis in Women (2000) (31)
Gangliocytoma masquerading as a prolactinoma. Case report. (1999) (31)
Genetic variation in insulin-like growth factors and brain tumor risk. (2008) (30)
Pituitary apoplexy following cardiopulmonary bypass: considerations for a staged cardiac and neurosurgical procedure. (1994) (30)
Natural History of Meningioma Development in Mice Reveals: A Synergy of Nf2 and p16 Ink4a Mutations (2007) (30)
Isolated oculomotor nerve palsy following apoplexy of a pituitary adenoma. (1992) (30)
Computer-based imaging and interventional MRI: applications for neurosurgery. (1999) (30)
A phase I trial of a new recombinant human beta-interferon (BG9015) for the treatment of patients with recurrent gliomas. (1997) (30)
Study Design for a Case Control Investigation of Cellular Telephones and Other Risk Factors for Brain Tumors in Adults (1999) (29)
δ-Aminolevulinic Acid Dehydratase Polymorphism and Risk of Brain Tumors in Adults (2005) (29)
Delayed CSF lavage for arteriographic and morphological vasospasm after experimental SAH. (1985) (28)
Transient abducens paresis after shunting for hydrocephalus. Report of two cases. (1981) (28)
EEG prior to hemispherectomy: correlation with outcome and pathology. (1995) (28)
Comprehensive Molecular Characterization of Urachal Adenocarcinoma Reveals Commonalities With Colorectal Cancer, Including a Hypermutable Phenotype. (2017) (28)
Molecular classification of brain tumor biopsies using solid-state magic angle spinning proton magnetic resonance spectroscopy and robust classifiers. (2008) (28)
ESTABLISHMENT OF AN IN VIVO MENINGIOMA MODEL WITH HUMAN TELOMERASE REVERSE TRANSCRIPTASE (2007) (28)
Posttraumatic Hydrocephalus (1984) (27)
Alternative splicing of CHEK2 and codeletion with NF2 promote chromosomal instability in meningioma. (2012) (27)
Sarcoid of the cauda equina. Case report. (1977) (27)
Immunological, biochemical, ultrastructural, and electrophysiological characteristics of a human glioblastoma-derived cell culture line. (1982) (27)
Testing the Angiogenic Potential of Cerebrovascular Malformations by Use of a Rat Cornea Model: Usefulness and Novel Assessment of Changes over Time (2005) (27)
Personal hair dye use and risks of glioma, meningioma, and acoustic neuroma among adults. (2006) (27)
IMAGE‐GUIDED CRANIOTOMY FOR CEREBRAL METASTASES: TECHNIQUES AND OUTCOMES (2007) (26)
Surgery for intractable epilepsy due to unilateral brain disease: a retrospective study comparing hemispherectomy techniques. (2014) (26)
A STAT3 Gene Expression Signature in Gliomas is Associated with a Poor Prognosis (2007) (26)
Imaging of human mesenchymal stromal cells: homing to human brain tumors (2012) (26)
Computer-assisted intra-operative magnetic resonance imaging monitoring of interstitial laser therapy in the brain: a case report. (1998) (26)
Expression of platelet derived growth factor and platelet derived growth factor receptor mRNA in a glioblastoma from a patient with Li-Fraumeni syndrome. (1995) (25)
Normal-pressure hydrocephalus: current understanding of diagnostic tests and shunting. (1982) (25)
Intraoperative magnetic resonance imaging in neurosurgery: the Brigham concept. (2006) (25)
Therapy of hematogenous melanoma brain metastases with endostatin. (2005) (25)
Frameless stereotaxy as an alternative to fluoroscopy for transsphenoidal surgery: use of the InstaTrak®-3000 and a novel headset (2002) (24)
A RECURRENT CRANIOPHARYNGIOMA ILLUSTRATES THE POTENTIAL USEFULNESS OF URINARY MATRIX METALLOPROTEINASES AS NONINVASIVE BIOMARKERS: CASE REPORT (2007) (24)
Analysis of the BRCA1 and BRCA2 genes in sporadic meningiomas (1997) (23)
Complication rate after cystectomy following pelvic radiotherapy: an international, multicenter, retrospective series of 682 cases (2019) (23)
Historical vignette: The radium bomb: Harvey Cushing and the interstitial irradiation of gliomas. (1996) (23)
Intracranial epidermoid tumors. A continuing diagnostic challenge. (1990) (23)
Endotoxic shock elicits greater endorphin secretion than hemorrhage. (1986) (23)
Meningioma and schwannoma risk in adults in relation to family history of cancer. (2004) (22)
Survival results from a phase I study of etanidazole (SR2508) and radiotherapy in patients with malignant glioma. (1998) (22)
Intraoperative magnetic resonance for the surgical treatment of lesions producing seizures (2002) (22)
COMPENSATION OF GEOMETRIC DISTORTION EFFECTS ON INTRAOPERATIVE MAGNETIC RESONANCE IMAGING FOR ENHANCED VISUALIZATION IN IMAGE‐GUIDED NEUROSURGERY (2008) (21)
Cancer of the nervous system (2013) (21)
Hypertrophic olivary degeneration after resection of a cerebellar tumor (2008) (21)
Criteria of brain death: review and comparison. (1975) (21)
Neuropeptides in cerebrospinal fluid. (1982) (21)
The microcirculation of cerebral arteries: a morphologic and morphometric examination of the major canine cerebral arteries. (1984) (20)
Laterality of Brain Tumors (2003) (20)
Metacognition and false recognition in patients with frontal lobe lesions: the distinctiveness heuristic (2005) (20)
Evaluation of intracranial cysts by intraoperative MR (1998) (20)
Decreases in Ventricular Volume Correlate with Decreases in Ventricular Pressure in Idiopathic Normal Pressure Hydrocephalus Patients Who Experienced Clinical Improvement after Implantation with Adjustable Valve Shunts (2004) (19)
Molecular aspects of neuro-oncology (1997) (19)
Functional recovery in T13-L1 hemisected rats resulting from peripheral nerve rerouting: role of central neuroplasticity. (2008) (19)
The contributions of Otfrid Foerster (1873-1941) to neurology and neurosurgery. (2001) (19)
Keyhole Limpet Haemocyanin in Experimental Bladder Cancer (2000) (19)
Changes in parenchymal and ventricular pressure with experimental epidural compression. (1984) (19)
Handedness and risk of brain tumors in adults. (2003) (18)
Craniopharyngioma: Preliminary Results of Stereotactic Radiation Therapy (1996) (18)
Neurosurgical considerations in supratentorial low-grade gliomas: experience with 175 patients. (1998) (18)
Intrathecal 5-[125I]iodo-2'-deoxyuridine in a rat model of leptomeningeal metastases. (1997) (18)
Three-dimensional reconstruction and surgical navigation in pediatric epilepsy surgery. (1997) (18)
Apoptosis in astrocytic neoplasms (2005) (17)
Perspectives of Cellular and Molecular Neurosurgery (2004) (17)
Meningiomas: science and surgery. (2007) (17)
Application of Open Source Image Guided Therapy Software in MR-guided Therapies (2007) (17)
Challenges in Contemporary Academic Neurosurgery (2006) (16)
The effect of prolactin and bombesin on the growth of meningioma-derived cells in monolayer culture (1993) (16)
Image guided neurosurgery: visualization of brain shift (1999) (16)
Therapeutic Anti-Angiogenesis for Malignant Brain Tumors (2001) (15)
Selective treatment of infants with myelomeningocele. (1979) (15)
Subdural hygroma of the spinal meninges: a case report. (1978) (14)
Arginine vasopressin causes morphological changes suggestive of fluid transport in rat choroid plexus epithelium (2004) (14)
Three-dimensional image reconstruction for low-grade glioma surgery. (1998) (14)
Three-Dimensional Reconstruction and Surgical Navigation in Pediatric Epilepsy Surgery (1998) (14)
Management of kidney cancer: canadian kidney cancer forum consensus update 2011. (2012) (14)
Hippocampal lesions: Effects on memory in rats (1968) (14)
Astrocytomas : diagnosis, treatment, and biology (1993) (13)
A phase I study of etanidazole and radiotherapy in malignant glioma. (1994) (13)
Clinical problems in the use of brain-death standards. (1983) (13)
Parathyroid Hormone-Related Protein and its Receptor in Human Glial Tumors (2000) (13)
From vision to reality: the origins of intraoperative MR imaging. (2011) (13)
A Genome-Wide Screen Reveals Functional Gene Clusters in the Cancer Genome and Identifies EphA 2 as a Mitogen in Glioblastoma (2006) (13)
Keyhole limpet haemocyanin in experimental bladder cancer: literature review and own results. (2000) (12)
Normal Pressure Hydrocephalus — Idiopathic Type Selection of Patients for Shunt Procedures (1977) (12)
Diagnostic retrieval monitoring in patients with frontal lobe lesions: Further exploration of the distinctiveness heuristic (2007) (12)
Benign brain tumors. Meningiomas, pituitary tumors, and acoustic neuromas. (1995) (12)
Surgery for cerebral gliomas: past, present, and future. (2000) (12)
The present and future of cerebral tumor surgery in children (2000) (12)
FACT-MNG: tumor site specific web-based outcome instrument for meningioma patients (2010) (12)
The importance of dopamine in the pathogenesis of experimental prolactinomas. (1990) (12)
The use of clinical practice guidelines (CPGs) to evaluate practice and control costs in ventriculoperitoneal shunt management. (1997) (11)
Inhibition of thromboxane synthase activity improves glioblastoma response to alkylation chemotherapy. (2010) (11)
Core Techniques in Operative Neurosurgery (2019) (11)
Polio vaccination and risk of brain tumors in adults: no apparent association. (2003) (11)
Cranial Computed Tomography in Subarachnoid Hemorrhage: Relationship Between Blood Detected by CT and Lumbar Puncture (1980) (11)
A 24-year-old woman with intractable seizures: review of surgery for epilepsy. (2008) (11)
The Importance of “Accessory” Outflow Pathways in Hydrocephalus after Experimental Subarachnoid Hemorrhage (1989) (10)
Corpus callosotomy in children. (1995) (10)
From heart to brain: the new definitions of death. (1980) (10)
The influence of Harvey Cushing on neuroradiologic therapy. (1996) (10)
Dopaminergic regulation of alpha-subunit secretion and messenger ribonucleic acid levels in alpha-secreting pituitary tumors. (1988) (10)
Mucinous cysts of the pituitary stalk. Report of two cases. (1989) (10)
Tumor surgery under local anesthesia (2001) (10)
Minimalist approach: functional mapping. (2002) (10)
Tissue cultures from cerebrospinal fluid specimens in the study of human brain tumors. (1978) (10)
An Anisotropic Material Model for Image Guided Neurosurgery (2004) (9)
Reoperation following Radiosurgery of Glioblastoma: Impact on Survival and Neurologic Status (1996) (9)
A Multicentered, Propensity Matched Analysis Comparing Laparoscopic and Open Surgery for pT3a Renal Cell Carcinoma. (2017) (9)
Integration of patient specific modeling and advanced image processing techniques for image-guided neurosurgery (2006) (9)
Ventricular Shunts (2002) (8)
Pathophysiology of brain death: intracranial aspects. (1988) (8)
Stereotactic techniques in managing pediatric brain tumors (1993) (8)
Compulsory spitting: An unusual manifestation of temporal lobe epilepsy (1994) (8)
The future of neurosurgery: a call to leadership. (2007) (8)
Three definitions of death. (1977) (8)
Predicting the Outcome From Hypoxic-Ischemic Coma: Medical and Ethical Implications (1985) (8)
Differential Display of Messenger Ribonucleic Acid (1995) (8)
Functional transplantation of the rat pituitary gland. (1998) (8)
The Neuroanatomy of Leonardo da Vinci (1992) (8)
Neurosurgery certification in member societies of the WFNS: global overview. (2011) (8)
Antegrade balloon occlusion of inferior vena cava during thrombectomy for renal cell carcinoma. (2013) (8)
Autocrine regulation of the production of the gaseous messenger nitric oxide in a glioblastoma cell line. (1994) (8)
Awake Craniotomy for Excision of Brain Metastases Involving Eloquent Cortex (2001) (7)
Precocious puberty following head injury. Case report. (1990) (7)
Commentary on: Abiraterone in Metastatic Prostate Cancer Without Previous Chemotherapy (2013) (7)
Historical vignette. The neurosurgeon's neurosurgeon: cushing operates on a Penfield. (1990) (7)
THE DEVELOPMENT OF RING‐SHAPED CONTRAST ENHANCEMENT IN A CASE OF CEREBELLAR DYSEMBRYOPLASTIC NEUROEPITHELIAL TUMOR: CASE REPORT (2008) (7)
Allocentric Visuospatial Processing in Patients with Cerebral Gliomas: A Neurocognitive Assessment (2000) (7)
CHAPTER 3 – The Origin of Meningiomas (2010) (7)
The importance of "accessory" outflow pathways in hydrocephalus after experimental subarachnoid hemorrhage. (1989) (7)
Dual isotope single-photon emission computerized tomography used for prediction of histology and survival in patients after high-dose radiotherapy for malignant astrocytoma (1996) (7)
NCCN adult brain tumor practice guidelines. (1997) (7)
Canadian guidelines for postoperative surveillance of upper urinary tract urothelial carcinoma. (2013) (7)
Technetium-99m HmPAO brain SPECT and outcome of hemispherectomy for intractable seizures. (1994) (7)
Kenneth McKenzie, Harvey Cushing, and the early neurosurgical treatment of spasmodic torticollis. (1991) (6)
The Harvard Neurosurgical Service at the Children's Hospital Boston and Brigham & Women's Hospital, 1912-2007. (2008) (6)
Clinical and Bacterial Risk Factors for Development of Post-Prostate Biopsy Infections. (2019) (6)
Management of advanced kidney cancer: Canadian Kidney Cancer Forum 2013 Consensus Update: Canadian Kidney Cancer Forum 2013. (2013) (6)
Moral disagreements during residency training. (1985) (6)
The development of neurosurgical techniques: The postoperative notes and sketches of Dr. Harvey Cushing (2005) (6)
Enumerating pelvic recurrence following radical cystectomy for bladder cancer: A Canadian multi-institutional study. (2016) (6)
Harvey Cushing operates on a child with tuberculosis of the spine. (1990) (6)
Morbidity of depth and subdural electrodes: Children and adolescents versus young adults (1994) (6)
Anaplastic variant of medulloblastoma mimicking a vestibular schwannoma (2006) (5)
Present and future applications of lasers in neurosurgery. (1993) (5)
Tracking Volumetric Brain Deformation During Image Guided Neurosurgery (2001) (5)
Use of intraoperative MRI in pituitary surgery (2002) (5)
Neurosurgery certification in member societies of the WFNS: Africa and the Middle East. (2011) (5)
Early experience with stereotactic radiation therapy in the management of intracranial lesions: The first 1200 treatments (1993) (5)
Predicting the outcome from hypoxic-ischemic coma: medical and ethical implications. (1986) (5)
Capturing Brain Deformation (2003) (5)
Non-rigid alignment of preoperative MRI, fMRI and DT-MRI with intraoperative MRI to enhance visualization and navigation in image-guided neurosurgery (2006) (5)
Selected human leukocyte antigen class II polymorphisms and risk of adult glioma (2011) (5)
Neurosurgery certification in member societies of the World Federation of Neurosurgical Societies (WFNS). The Americas. (2010) (5)
Tension Pneumocephalus of the Cranial Subdural Space (1979) (5)
Occipital interhemispheric acute subdural hematoma treated by lambdoid suture tap. (1985) (5)
Imaging of primary rhabdomyosarcoma of the diaphragm. (2000) (4)
Neurosurgery certification in member societies of the WFNS: Europe. (2010) (4)
Idiopathic pinealitis. Case report. (1999) (4)
Dense deformation field estimation for brain intraoperative images registration (2004) (4)
Neuropeptide investigations with an ovine surgical model. (1986) (4)
[The concept of suppressor genes in the molecular biology of central nervous system tumors]. (1989) (4)
Stereotactic Radiotherapy for Meningiomas (1996) (4)
Conceptual and practical issues in the declaration of death by brain criteria. (1991) (4)
Neurosurgery: An Introductory Text (1995) (4)
MP28-14 TARGETING HER2 WITH TRASTUZUMAB-DM1 (T-DM1) IN HER2-OVEREXPRESSING BLADDER CANCER (2014) (4)
18 – Neural Stem Cells (2008) (4)
A STAT 3 Gene Expression Signature in Gliomas is Associated with a Poor Prognosis (2007) (4)
Three-dimensional Reconstruction for Cortical Surgery: The Brigham and Women's Hospital Experience (2001) (4)
Apoptosis in tumors of the central nervous system (1997) (4)
The Surgical Art of Harvey Cushing (1992) (4)
Medical ethics in neurology and neurosurgery. (1985) (4)
The emerging field of neurosurgical oncology: novel techniques to optimize outcomes and minimize mishaps. (2007) (3)
Report of the Ninth International Symposium of the Foundation for Promotion of Cancer Research: basic and clinical research in brain tumors. (1996) (3)
Kenneth McKenzie, Harvey Cushing, and the Early Neurosurgical Treatment of Spasmodic Torticollis (1991) (3)
Congress of Neurological Surgeons (1998) (3)
Acute quadriplegia due to bilateral cerebral metastases (1981) (3)
Neuro-glial hamartoma of the suprasellar cistern. (1994) (3)
Do Not Learn a Technique, Learn the Biology Underlying the Disease: Techniques Evolve, Biology Prevails. (2019) (3)
Using liquid biopsy to assess the genomic landscape of metastatic urothelial carcinoma (2017) (3)
Imaging and visual analysis - Toward real-time image guided neurosurgery using distributed and grid computing (2006) (3)
Cerebrospinal fluid anion transport: studies of pertechnetate in unanesthetized sheep. (1985) (3)
Outcomes of Magnetic Resonance Imaging–Ultrasound Fusion Prostate Biopsy of PI-RADS 3, 4, and 5 Lesions (2018) (3)
Comorbidity status does not independently predict survival outcomes after radical nephroureterectomy for upper tract urothelial carcinoma. (2013) (3)
Grid-Enabled Software Environment for Enhanced Dynamic Data-Driven Visualization and Navigation During Image-Guided Neurosurgery (2007) (3)
The p27/Kip1 Locus Shows No Loss of Heterozygosity in Human Pituitary Adenomas (1999) (3)
History of neurosurgery for intracranial mass lesions. (2001) (3)
Molecular subtyping reveals luminal bladder tumors have lower rates of pathological upstaging at radical cystectomy (2019) (3)
A phase II study of prolonged daily temozolomide for low-grade glioma (2005) (3)
Perioperative Use of Transcranial Magnetic Stimulation (2001) (3)
PD28-04 DETECTION OF ANDROGEN RECEPTOR VARIANT 7 (AR-V7) IN WHOLE BLOOD RNA OF METASTATIC CASTRATION-RESISTANT PROSTATE CANCER (MCRPC) PATIENTS TREATED WITH ABIRATERONE ACETATE (ABI) (2016) (3)
Difficult decisions in managing patients with benign brain tumors. (1989) (3)
PETER Bent Brigham Hospital. (1991) (3)
Composition, clinical suitability and future prospects of a 0.5-T MR system for interventional use (1997) (3)
Ultrastructural and electrophysiological features of meningioma whorls in tissue culture (1979) (3)
World Neurosurgery and the World Federation of Neurosurgical Societies (WFNS). (2010) (3)
Commentary on: Quality-of-Life Effects of Prostate-Specific Antigen Screening (2013) (2)
Linac Radiosurgery for Meningiomas (1998) (2)
Intraoperative Cortical Function Localization Techniques (2001) (2)
[Harvey Cushing: neurosurgeon and artist]. (1990) (2)
Minimally Invasive Treatment for Brain Tumors (2005) (2)
The birth of World Neurosurgery. (2014) (2)
CHAPTER 18 – Decision Making in Meningiomas (2010) (2)
Comprar Core Techniques in Operative Neurosurgery Expert Consult - Online and Print | Rahul Jandial | 9781437709070 | Saunders (2011) (2)
Brain Death in Children Guidelines and Experience at the Massachusetts General Hospital (1989) (2)
DNA repair enzyme expression and differential response to temozolomide in a patient with both glioblastoma and metastatic pancreatic neuroendocrine tumor. (2008) (2)
Mapping of Human Visual Cortex (2005) (2)
485 MULTI-INSTITUTIONAL QUALITY OF CARE INITIATIVE FOR NON-METASTATIC MUSCLE-INVASIVE TRANSITIONAL CELL CARCINOMA OF THE BLADDER: PHASE 1 (2011) (2)
A prospective randomized single-centre trial evaluating an ERAS protocol versus a standard protocol for patients treated with radical cystectomy and urinary diversion for bladder cancer (2017) (2)
2023 Survival results of a phase I study of etanidazole and radiotherapy in patients with malignant glioma (1996) (2)
MP75-09 THE NATURAL HISTORY OF RENAL FUNCTION AFTER SURGICAL MANAGEMENT OF RENAL CELL CARCINOMA: RESULTS FROM THE CANADIAN KIDNEY CANCER INFORMATION SYSTEM (2016) (2)
Transsphenoidal pituitary resection with intraoperative MR guidance: preliminary results (1999) (2)
Towards a lineage-based classification system for gliomas: innovation or imagination? (1998) (2)
Endogenous growth inhibition of angiogenesis in brain tumors (2007) (2)
Al Rhoton as neurosurgeon of the year. (2011) (2)
Image-guidance with updated images in the intraoperative MRI (2000) (2)
Minimally invasive neurosurgery (2005) (2)
Xanthomatous hypophysitis. (1998) (2)
[Pilot study on early diagnosis of renal cell carcinoma by sonography]. (1999) (2)
Intraoperative magnetic resonance imaging guidance for intracranial neurosurgical procedures (1999) (2)
56. Normal Pressure Hydrocephalus (2012) (2)
Idiopathic Intracranial Hypertension: A Neurosurgical Perspective (2007) (1)
Image-Guidedat Brigham and Women's Hospital The Integration of Imaging, Navigation, and Interventional Devices (2006) (1)
132 Initial clinical results of linac stereotactic radiosurgery (SRS) and stereotactic radiotherapy (SRT) for pituitary adenomas (1997) (1)
Enhanced sensitivity for multidimensional high-resolution magic-angle-spinning 1 HMR spectroscopy (2007) (1)
INTRATHECAL 5-[125 I] IODO-2-DEOXYUFIDINE IN A RAT MODEL OF .PTOMENINGEAL METASTASES (1997) (1)
Positron emission tomography for the management of brain tumors (2004) (1)
LATE RECURRENCE OF LEYDIG- AND SERTOLI CELL TUMORS OF THE TESTIS: THE CASE FOR PRIMARY RETROPERITONEAL LYMPH NODE DISSECTION? (1999) (1)
THE LANDSCAPE OF HER2 ALTERATIONS IN MUSCLE‐INVASIVE BLADDER CANCER: IMPACT ON PATIENT SELECTION FOR TARGETED THERAPIES?: MP44‐08 (2017) (1)
Incidence and Management of Complications of Transsphenoidal Operation for Pituitary Adenomas (1988) (1)
PD51-11 REPORTING RADICAL CYSTECTOMY OUTCOMES FOLLOWING IMPLEMENTATION OF ENHANCED RECOVERY AFTER SURGERY (ERAS) PROTOCOLS (2020) (1)
Technical considerations for Nd:YAG intracranial LITT in an iMRI unit (1999) (1)
MP36-17 CANONICAL NOTCH2 SIGNALING PROMOTES TUMOR GROWTH AND METASTASIS IN BLADDER CANCER THROUGH CELL CYCLE PROGRESSION, DEDIFFERENTIATION AND EMT (2015) (1)
The management of skull base tumors. (2012) (1)
Management of Childhood Brain Tumors (1991) (1)
The anti-epidermal growth factor receptor (EGFR) monoclonal antibody, C225, enhances radiation-induced apoptosis in primary glioma cell lines through mediation of MAPK/JNK/p38 signaling pathways (2001) (1)
Neural transplantation. (1988) (1)
Glycine as a biomarker in brain tumors (2008) (1)
A simple method of scalp localization using multiplanar reconstruction of MR images. (1998) (1)
Prostate-specific Antigen Testing: Men's Responses to 2012 Recommendation Against Screening (2014) (1)
Science in Neurosurgery: The Importance of the Scientific Method (1998) (1)
2239 CLINICAL AND GENOMIC ANALYSIS OF METASTATIC DISEASE PROGRESSION IN A BACKGROUND OF BIOCHEMICAL RECURRENCE (2013) (1)
World Federation of Neurosurgical Societies: 2009-2013. (2014) (1)
Retention of an appropriate astrocytic response to retinoids by human brain tumors comprised of predominantly glial fibrillary acidic protein-positive cells. (1998) (1)
Intraoperative Magnetic Resonance Imaging Using the GE Signa SP System (2002) (1)
CHAPTER 22 – Magnetic Resonance Image Guided Neurosurgery (2008) (1)
Concurent adjacent meningioma and astrocytoma : a report of three cases and review of the literature. Commentary (1995) (1)
Alternative Splicing of CHEK 2 and Codeletion with NF 2 Promote Chromosomal Instability in Meningioma 1 (2012) (1)
Diagnosis and surgical treatment of pituitary lesions. (1977) (1)
High Performance Computing in Image Guided Therapy: Computer Assisted Three-Dimensional Planning and Real-Time Navigation for Neurosurgical Procedures (2001) (1)
Cellular Telephones and Brain Tumors (2001) (1)
Lead, Genetic Susceptibility and Risk of Adult Brain Tumors (2006) (1)
Stemming the Tide: Infectious Complications After Prostate Biopsy. (2015) (1)
Tumor regression grading after neoadjuvant chemotherapy in bladder cancer: Validation in an independent cohort (2017) (1)
Urothelial carcinoma in bladder diverticula: A multicenter analysis of characteristics and treatment outcome in 110 patients (2018) (1)
Case records of the Massachusetts General Hospital. Weekly clinicopathological exercises. Case 39-1989. A 63-year-old woman with a polypoid nasal mass and a recent grand-mal seizure. (1989) (1)
Growth factors, glial cells and neuro-oncology. Perspectives for treatment? (1997) (1)
How to Perform Surgery for Intracranial (Convexity) Meningiomas (2009) (1)
PROGNOSTIC IMPACT OF IMMUNOHISTOCHEMICAL CLASSIFICATION OF BLADDER CANCER ACCORDING TO LUMINAL (UROPLAKIN III) AND BASAL (CYTOKERATIN 5/6) MARKERS: MP04‐07 (2017) (1)
Interactive MR image guidance for neurosurgical and minimally invasive procedures (1999) (1)
Harvey Cushing's postoperative sketches of pediatric brain tumors (1991) (1)
Brain Death in the Intensive Care Unit (1987) (1)
MP60-12 MULTI-INSTITUTIONAL QUALITY CARE INITIATIVE TO IMPROVE THE CARE OF PATIENTS WITH MUSCLE INVASIVE BLADDER CANCER (2014) (1)
MP57-20 VARIANT HISTOLOGY DOES NOT PREDICT SURVIVAL OUTCOMES AFTER RADICAL NEPHROURETERECTOMY FOR UPPER TRACT UROTHELIAL CARCINOMA: RESULTS FROM THE CANADIAN UPPER TRACT COLLABORATION (2015) (0)
Subject Index Vol. 68, 1997 (1997) (0)
PD38-01 NOTCH2-HEY AXIS PROMOTES TUMOR GROWTH IN BLADDER CANCER THROUGH CELL CYCLE PROGRESSION AND DEDIFFERENTIATION (2016) (0)
POD-7.04: The Role for Radical Cystoprostatectomy in Patients with Clinical T4b Bladder Cancer (2008) (0)
IS20I, a Specific &agr;v&bgr;3 Integrin Inhibitor, Reduces Glioma Growth in Vivo (2003) (0)
PD17-11 POSITIVE SURGICAL MARGINS AFTER PARTIAL NEPHRECTOMY FOR RENAL CELL CARCINOMA: PREDICTORS AND IMPACT ON ONCOLOGICAL OUTCOMES (2014) (0)
Novel gene expression patterns associated with progression and adverse outcome in high-grade gliomas (2005) (0)
Book Review The Ethics of Surgical Practice: Cases, Dilemmas, and Resolutions By James W. Jones, Laurence B. McCullough, and Bruce W. Richman. 340 pp. New York, Oxford University Press, 2008. $99 (cloth); $24.95 (paper). 978-0-19-532108-1 (cloth); 978-0-19-532109-8 (paper). (2009) (0)
Molecular and therapeutic aspects of advanced urachal cancer (2017) (0)
Conventionally fractionated stereotactic radiotherapy for vestibular schwannoma: long-term outcome and cranial nerve function (2001) (0)
Harvey Cushing's legacy. (1989) (0)
O-9-126 Endogenous growth inhibition of glioma (1997) (0)
PD10-12 CLINICAL OUTCOMES FOLLOWING LAPAROSCOPIC MANAGEMENT OF PT3 RENAL MASSES: A MULTI-INSTITUTIONAL ANALYSIS (2014) (0)
MP34-12 TARGETING IGF-BP2 AND 5 WITH THE BISPECIFIC ANTISENSE OLIGODEOXYNUCLEOTIDE OGX-225 IN CHEMORESISTANT BLADDER CANCER (2014) (0)
Chapter 162 – Meningiomas (2003) (0)
PD12-03 ACTIVE SURVEILLANCE IN 853 MEN WITH LOW AND INTERMEDIATE RISK PROSTATE CANCER (2014) (0)
925 STAT1 inhibition restored chemotherapy sensitivity in cisplatin/gemcitabine resistant bladder cancer (2016) (0)
Youtube clips to select low-grade low-stage recurrent Non-Muscle-Invasive Bladder Cancers (NMIBC) for office fulguration, a multinational multi institutional study (2021) (0)
Surgical Treatment for Epilepsy in Developing Countries. Authors' reply (2009) (0)
Natural History of Meningioma Development in Mice Reveals: A Synergy of and Mutations-0 (2011) (0)
PD31-09 CLINICAL FACTORS PREDICTING PATHOLOGICAL POSITIVE LYMPH NODES IN CLINICALLY NODE NEGATIVE PATIENTS TREATED WITH NEOADJUVANT CHEMOTHERAPY AND RADICAL CYSTECTOMY (2015) (0)
MP67-16 GETTING ADVANTAGE FROM THE “TEACHABLE MOMENT” AT INITIAL DIAGNOSIS OF PROSTATE CANCER - RESULTS OF A RANDOMIZED CONTROLLED PHYSICAL EXERCISE PROGRAM (2020) (0)
737 The interval between diagnosis and radical cystectomy does not impact the outcomes of patients treated with neoadjuvant chemotherapy (2015) (0)
MP72-15 THE INTERVAL BETWEEN DIAGNOSIS AND RADICAL CYSTECTOMY DOES NOT IMPACT THE OUTCOMES OF PATIENTS TREATED WITH NEOADJUVANT CHEMOTHERAPY (2015) (0)
&agr;v&bgr;3 and &agr;v&bgr;5 Integrin Expression in Meningiomas (2000) (0)
Atypical and malignant meningiomas : a clinicopathological review. Comments (1993) (0)
Angiostatin Suppresses Malignant Glioma Growth in Vivo1 (2006) (0)
1145 Predicting response to neoadjuvant cisplatin chemotherapy in bladder cancer with a novel gene expression signature (2016) (0)
1492 BIOCHEMICAL PROGRESSION FREE SURVIVAL AFTER RADICAL PROSTATECTOMY IN MEN WITH HIGH-RISK CLINICALLY LOCALISED PROSTATE CANCER (2013) (0)
Perspectives of Cellular and Molecular Neurosurgery. (2004) (0)
Virtual-reality technology is giving surgeons the equivalent of x-ray vision , helping them to remove tumors more effectively , to minimize surgical wounds and to avoid damaging critical tissues (1999) (0)
MRI-Guided and Controlled Laser-Induced Interstitial Thermal Therapy of Brain Tumors Using Integrated Navigation and Thermal Mapping (2014) (0)
Abstracts from the Joint Section on Tumors (2004) (0)
Comprar Low Grade Gliomas · Diagnosis and Treatment | Black, Peter M. | 9781588292599 | Springer (2008) (0)
MP49-09 ACTIVATION OF IFN/STAT1 SIGNALING IN CISPLATIN/GEMCITABINE RESISTANT BLADDER CANCER (2015) (0)
CHARACTERISTICS OF IRREVERSIBLY CONSTRICTED CEREBRAL BLOOD VESSELS. (1982) (0)
CHAPTER 7 – Biology of Meningiomas (2010) (0)
127 Small Cell Carcinoma of the Bladder: Retrospective Long Term Outcomes of Chemoradiation (2019) (0)
MP49-01 NEXT GENERATION SEQUENCING OF CELL FREE DNA REVEALS GENOMIC ABERRATIONS IN METASTATIC UROTHELIAL CARCINOMA (2016) (0)
PD27-09 INCIDENCE AND SIGNIFICANCE OF THROMBO-EMBOLIC EVENTS IN BLADDER UROTHELIAL CARCINOMA PATIENTS UNDERGOING NEO-ADJUVANT CHEMOTHERAPY AND RADICAL CYSTECTOMY: RESULTS FROM MULTI-CENTRE NORTH-AMERICAN AND EUROPEAN CONTEMPORARY DATA (2016) (0)
1016 Are continent urinary diversions feasible at the time of radical cystectomy after pelvic radiotherapy? Analysis of a large retrospective multicenter series (2016) (0)
Combining High Resolution Magic Angle Spinning H 1 NMR and Molecular Genomics Predicts Survival in Brain Tumor Patients Better than Either Methodology Alone (2009) (0)
Tumor-related Venous Obstruction and Development of Peritumoral Brain Edema in Meningiomas (1998) (0)
The emerging field of third circulation research. (2007) (0)
Abstract B103: Intralesional administration of CTLA-4 blocking monoclonal antibodies as a means to optimize bladder cancer therapy (2016) (0)
845 Timing of the development of metastasis and initiation of treatment are important prognostic factors in prostate cancer (2016) (0)
641 MANAGEMENT OF THE INTRAVESICAL URETER AND BLADDER CUFF DURING RADICAL NEPHROURETERECTOMY: OUTCOMES FROM THE CANADIAN UPPER TRACT COLLABORATION (2012) (0)
Radiation therapy for gliomas (2000) (0)
MP26-15 MOLECULAR SUBTYPING REVEALS LUMINAL BLADDER TUMORS HAVE LOWER RATES OF PATHOLOGICAL UPSTAGING AT RADICAL CYSTECTOMY (2019) (0)
Expression of Structural Proteins in Cerebral Vascular Malformations (1998) (0)
Inhibition of LIM-SH3 domain protein 1 (LASP1) augments the anti-cancer effect of cisplatin in bladder cancer (2017) (0)
Clinical Cancer esearch an Cancer Biology omic Profiling Reveals Alternative Genetic Pathways of ingioma Malignant Progression Dependent R he Underlying NF 2 Status (2010) (0)
Retractile mesenteritis mimicking an adrenal tumor. (1999) (0)
Neurosurgical Procedures Monitored by Intraoperative MRI (2007) (0)
MP47-04 REFINING SELECTION CRITERIA FOR NEOADJUVANT CHEMOTHERAPY IN PATIENTS WITH MUSCLE INVASIVE BLADDER CANCER: COMBINING CLINICAL RISK FEATURES AND INTRINSIC MOLECULAR SUBTYPES (2018) (0)
Her2 alterations in muscle-invasive bladder cancer: There is more than protein expression in patient selection for targeted therapy (2017) (0)
[Design, clinical suitability and future aspects of a 0.5 T MRI special system for interventional use]. (1997) (0)
209 A phase 1 clinical trial assessing an intravesical administered second-generation antisense oligonucleotide targeting heat shock protein 27 in bladder cancer (2016) (0)
Surgery of intrinsic cerebral tumors. Commentary (2007) (0)
PD03-06 RADICAL PROSTATECTOMY FOLLOWING ACTIVE SURVEILLANCE IS ASSOCIATED WITH INCREASED RATES OF UNFAVOURABLE PATHOLOGY (2016) (0)
Muscle invasive bladder cancer: A single sample patient assay to predict molecular subtypes and benefit of neoadjuvant chemotherapy (2017) (0)
2242 Stereotactic radiosurgery (SRS) in the management of pediatric brain tumors (1999) (0)
The Contributions of Dr. Roswell Park to Epilepsy and Spinal Surgery (1998) (0)
MP84-08 PATHOLOGICAL UPSTAGING OF CLINICAL T1 RENAL CELL CARCINOMA: A MULTI-INSTITUTIONAL ANALYSIS OF OUTCOMES (2015) (0)
MP-08.12 Bacterial Growth in the Rectum and Urine Before and After Trans-Rectal Ultrasound-Guided Prostate Biopsy (2011) (0)
MP01-17 ASSOCIATION OF DISTANCE TO TREATMENT FACILITY WITH SURVIVAL AND QUALITY OUTCOMES FOLLOWING RADICAL CYSTECTOMY: A MULTI-INSTITUTIONAL STUDY (2016) (0)
847 PEX-producing Human Neural Stem Cells Inhibit Tumor Growth in a Mouse Glioma Model. (2005) (0)
Neurosurgical aspects of epilepsy in childhood and adolescence. (1973) (0)
Stem Cells to Treat Neurological Diseases-Implications for Neurosurgery (2014) (0)
929 Targeting lactate transporters for the treatment of urothelial carcinoma (2016) (0)
Surgical Treatment for Epilepsy in Developing Countries—Reply (2009) (0)
Magnetic Resonance Image-Guided Neurosurgery∗∗Reproduced from the first edition, Handbook of Neuro-Oncology Neuroimaging, ed. F. Jolesz and H. Newton, Academic Press, 2007. (2008) (0)
Journal WatchIntermittent Versus Continuous Androgen Deprivation in Prostate Cancer (2013) (0)
Bladder Cancer: Basic Research & Pathophysiology IIIPD38-01 NOTCH2-HEY AXIS PROMOTES TUMOR GROWTH IN BLADDER CANCER THROUGH CELL CYCLE PROGRESSION AND DEDIFFERENTIATION (2016) (0)
Nitric oxide (no) production by a glioblastoma (GBM) cell line: Possible implications for pathogenesis and radiation therapy (1993) (0)
5 – Intraoperative Visualization (2000) (0)
Peter Bent Brigham Hospital. (1991) (0)
MP62-09 COMPARISON OF PATHOLOGICAL AND ONCOLOGICAL OUTCOMES OF MEN ON ACTIVE SURVEILLANCE PROGRESSING TO RADICAL PROSTATECTOMY WITH A MATCHED COHORT OF MEN UNDERGOING IMMEDIATE RADICAL PROSTATECTOMY IN A SINGLE INSTITUTION (2014) (0)
Comprar Functional Imagery, An Issue of Neurosurgery Clinics | Alexandra Golby | 9781455704729 | Saunders (2011) (0)
758 Minimally-invasive establishment of urological cancer xenografts: A high-precision approach with ultrasound-guidance (2015) (0)
Tumor Regression Medulloblastoma and Deliver a Therapeutic Gene Leading to Human Neural Stem Cells Target Experimental Intracranial (2006) (0)
Magnetic Resonance Imaging-Guided Stereotactic Biopsy in the Central Nervous System (2003) (0)
Cost-Effective Use of Institutional Clinical Practice Guidelines in the Management of Ventriculoperitoneal Shunt Malfunction Paper #728 (1996) (0)
World Neurosurgery Neurosurgeon of the Year 2012: Liangfu Zhou. (2012) (0)
Chapter 160 – Malignant Gliomas (2003) (0)
Does associated CIS with MIBC impact on neoadjuvant chemotherapy? Results of an International consortium (2017) (0)
The impact of time to metastasis on survival in treatment-naïve prostate cancer patients. (2015) (0)
UP-03.117 Adjuvant Chemotherapy for Upper Tract Urothelial Carcinoma Treated with Nephroureterectomy: Assessment of Adequate Renal Function and Impact on Outcome (2011) (0)
A 24-Year-Old Woman With Intractable Seizures (2017) (0)
Transsphenoidal surgery for visual loss in patients with pituitary adenomas. (1990) (0)
CHAPTER 10 – Angiogenesis in Meningiomas (2010) (0)
MP16-14 RECTAL CULTURE PRIOR TO PROSTATE BIOPSY IDENTIFIES MEN AT RISK FOR INFECTION: A MULTI-INSTITUTIONAL INTERNATIONAL COLLABORATIVE STUDY (2014) (0)
Stereotactic and Image-Guided Surgery: Abstracts (1997) (0)
P-3-240 Anti-angiogenic therapy of gliomas (1997) (0)
1066 TSPAN8 EXPRESSION IN RENAL CELL CARCINOMA IS A POOR PROGNOSTIC FACTOR AND A NOVEL THERAPEUTIC TARGET (2016) (0)
Madjid Samii: neurosurgeon of the year 2013. (2013) (0)
MP13-20 SECOND-GENERATION ANTISENSE OLIGONUCLEOTIDE - HSP27 A NEW INTRAVESICAL TREATMENT FOR BLADDER CANCER: PHASE 1CLINICAL TRIAL. (2016) (0)
Abstract 5397: Characterizing the genomic landscape of bladder cancer with circulating tumor DNA (2017) (0)
1479 CLINICALLY SIGNIFICANT URETHRAL STRICTURE AND/OR SUBCLINICAL URETHRAL STRICTURE AFTER HIGH-INTENSITY FOCUSED ULTRASOUND PARADOXICALLY CORRELATES WITH DISEASE-FREE SURVIVAL IN LOCALIZED PROSTATE CANCER (2012) (0)
650 A multi-institutional analysis of pathological and survival outcomes in patients with clinically node positive urothelial bladder cancer treated with neoadjuvant chemotherapy and radical cystectomy (2015) (0)
Biological characterization of cisplatin-resistant bladder cancer: Implications for second-line treatments? (2018) (0)
MP47-09 COST-EFFECTIVENESS ANALYSIS OF A BIOMARKER-BASED APPROACH TO SELECT PATIENTS WITH MUSCLE-INVASIVE BLADDER CANCER FOR NEOADJUVANT CHEMOTHERAPY (2018) (0)
NOTCH2 IN THE BLADDER PROMOTES TUMOR DEVELOPMENT AND LEADS TO MORE MALIGNANT PHENOTYPE.: MP65‐05 (2018) (0)
PD12-12 COMPLICATION RATES AFTER RADICAL CYSTECTOMY AFTER RADIOTHERAPY: AN INTERNATIONAL, MULTICENTER RETROSPECTIVE STUDY ON 609 CASES (2016) (0)
5- [125 I] IOSO- 2-DEOXYURIDINE IN THE RADIOTERAPYOF RAINTUMORSIN RATS (1998) (0)
Book ReviewModern Neurosurgery 1 (1983) (0)
PD60-01 DEFINITIVE RADIATION-BASED THERAPY FOR MUSCLE-INVASIVE BLADDER CANCER (2020) (0)
The impact of smoking on genomic alterations in muscle-invasive bladder cancer (2018) (0)
T-DM1, a novel HER2 antibody-cytotoxic drug conjugate, has anti-metastatic potential and is a promising targeted therapy for bladder cancer with HER2 IHC score 2+/3+ (2017) (0)
COMPUTER-ASSISTED INTRAOPERATIVE MAGNETIC RESONANCE IMAGING MONITORING OF INTERSTITIAL LASER THERAPY IN THE BRAIN : A CASE REPORT (2019) (0)
CHARACTERIZATION OF NON-FUNCTIONING PITUITARY ADENOMAS BY LIGHT AND ELECTRON MICROSCOPIC IMMUNOCYTOCHEMISTRY (1986) (0)
O-12-180 Chromosomal deletions rather than microsatellite instability are important in the pathogenesis of oligodendrogliomas (1997) (0)
T‐DM1, A NOVEL HER2 ANTIBODY‐CYTOTOXIC DRUG CONJUGATE, HAS ANTI‐METASTATIC POTENTIAL AND IS EFFECTIVE IN BLADDER CANCER WITH HER2 IHC SCORE 2+/3+: MP98‐03 (2017) (0)
Erratum to "The natural history of renal function after surgical management of renal cell carcinoma: Results from the Canadian Kidney Cancer Information System" [Urol Oncol 34(11) (2016) 486.e1-486.e7]. (2017) (0)
INTERVENTIONAL AND INTRAOPERATIVE MAGNETIC RESONANCE IMAGING 1 (2000) (0)
Li-Fraumeni syndrome . mRNA in a glioblastoma from a patient with and platelet derived growth factor receptor Expression of platelet derived growth factor (0)
INHIBITION OF PEG10 MAY BE A NOVEL TREATMENT STRATEGY FOR A SUBSET OF BLADDER CANCER.: MP65‐03 (2017) (0)
1046 Evaluation of carbonic anhydrase IX as a potential therapeutic target in urothelial carcinoma (2016) (0)
RESULTS OF NEPHRON-SPARING SURGERY OF 33 CENTRALLY LOCATED RENAL TUMORS (1999) (0)
CHAPTER 64 – Challenges and Opportunities in Future Meningioma Research and Care (2010) (0)
Predicting the Outcome From Hypoxic-Ischemic Coma: Ethical Implications-Reply (1986) (0)
Chromosomal deletions rather than microsatellite instability are important in the pathogenesis of human oligodendrogliomas (1998) (0)
Chapter 36 – Meningiomas (2012) (0)
Disease and patient’s characteristics in elderly (≥75 years) treated with radical cystectomy: results of a large multicentre retrospective series (2018) (0)
MP41-14 UROTHELIAL CARCINOMA IN BLADDER DIVERTICULA: A MULTICENTER ANALYSIS OF CHARACTERISTICS AND TREATMENT OUTCOME (2018) (0)
Phase II Tria l o f the Ant iangiogenic Agent Thal idomide in Pat ients With Recurrent High-Grade Gl iomas (2000) (0)
MP45-04 PATERNALLY EXPRESSED GENE-10 PROMOTES CELL GROWTH AND INVASION OF BLADDER CANCER (2016) (0)
MP1-07 ENRICHMENT OF CIRCULATING TUMOR CELLS IN PATIENTS WITH LOCALIZED PROSTATE CANCER USING A MICROFLUIDIC DEVICE (2015) (0)
CHAPTER 20 – Use of Three-Dimensional Reconstructed Magnetic Resonance Imaging Data for Neurosurgical Planning (1994) (0)
The Cartesian Computer (1974) (0)
On the Initiation of World Neurosurgery (2010) (0)
THE PROGNOSTIC SIGNIFICANCE OF TNM STAGING IN BLADDER CANCER AFTER NEOADJUVANT CHEMOTHERAPY CAN BE ENHANCED WITH TUMOR REGRESSION GRADING: MP34‐05 (2017) (0)
Predicting the Outcome From Hypoxic-Ischemic Coma-Reply (1986) (0)
CHAPTER 62 – Emerging Surgical Techniques for the Treatment of Meningiomas (2010) (0)
Transplantation and Gene Therapy: Abstract (1997) (0)
MP57-18 SHORT-TERM OUTCOME OF METASTASECTOMY IN RENAL CELL CARCINOMA: THE CANADIAN KIDNEY CANCER INFORMATION SYSTEM INITIAL EXPERIENCE. (2014) (0)
Clinical and outcome characteristics of the cancer genome atlas (TCGA) bladder cancer cohort: Is it representative? (2017) (0)
201-thallium SPECT in childhood brain tumors (CBT) - 106 studies in 76 patients - a six year experience (1995) (0)
MP77-01 NATURAL HISTORY OF PROSTATIC LESIONS ON SERIAL MULTIPARAMETRIC MRI. (2015) (0)
774 ARV7 detected by a novel whole-blood RT-PCR assay correlates with outcomes in metastatic castration-resistant prostate cancer (mCRPC) patients treated with abiraterone acetate (ABI) (2016) (0)
532 Final pathologic stage after neoadjuvant chemotherapy and radical cystectomy for bladder cancer: Does pT0 predict better survival than pTa/pTis/pT1? (2015) (0)
High Performance Computing in Image Guided Therapy (2001) (0)
Hydrocephalus and Disorders of Cerebrospinal Fluid Flow (2003) (0)
Prognostic factors of adult medulloblastoma in the MRA ERA (1998) (0)
311 Multicentre experience of uptake of renal tumour biopsies for small renal masses (2014) (0)
Functional Recovery in T13 Spinal Cord Injury Rats Resulting from Peripheral Nerve Rerouting: Role of the Central Nervous System Neuroplasticity: 826 (2006) (0)
Section on tumors biennial meeting (2007) (0)
INTRODUCTION — Most meningiomas are benign, but their location in the central nervous system can cause serious morbidity and/or mortality. The epidemiology, risk factors, and pathologic classification of meningiomas will be reviewed here. Other topics on meningioma include: (2013) (0)
MP55-09 ASSOCIATION OF AN IMMUNE-GENE SIGNATURE WITH PATHOLOGIC RESPONSE AND OUTCOME AFTER NEOADJUVANT PEMBROLIZUMAB (PEMBRO), COMPARED TO NEOADJUVANT CHEMOTHERAPY (NAC), IN MUSCLE-INVASIVE BLADDER CANCER (MIBC) (2020) (0)
MP61-03 EVALUATION OF LACTATE TRANSPORTERS AS POTENTIAL THERAPEUTIC TARGET IN UROTHELIAL CARCINOMA (2016) (0)
767 Risk factors for bladder cancer recurrence after nephroureterectomy for upper tract urothelial tumors: A multicenter analysis of 742 patients (2012) (0)
SPECT-MR Image Fusion in the Intraoperative MR for Guidance of Neurosurgical Tumor Resection: 823 (1997) (0)
Book Review Principles of Neurosurgery Edited by Robert G. Grossman, with Winifred J. Hamilton. 484 pp., illustrated. New York, Raven Press, 1991. $159. (1992) (0)
Tables Table 1 : Laser parameters and imaging sequences Table 2 : Sequential processes during pixel subtraction Table 3 : Laser effects on tissue Figures (2017) (0)
620 Complication rates after radical cystectomy following any previous abdominal-pelvic-perineal radiotherapy: An international, multicenter retrospective study on 609 cases (2016) (0)
MP49-13 LIM-SH3 DOMAIN PROTEIN 1 KNOCKDOWN INHIBITS CELL GROWTH AND ENHANCES ACTIVITY OF CISPLATIN IN BLADDER CANCER. (2015) (0)
CHAPTER 24 – Parasagittal and Falx Meningiomas (2010) (0)
The XIV World Congress of Neurosurgery: August 30-September 4, 2009, Boston, Massachusetts. (2010) (0)
Pediatric Low-grade Gliomas: Prognosis with Proton Magneti Resonance Spectroscopic Imaging (1998) (0)
MP40-02 INCREASED UPTAKE OF RENAL TUMOUR BIOPSIES FOR SMALL RENAL MASSES – RESULTS OF A MULTICENTRE CANADIAN EXPERIENCE (2014) (0)
Book Review Surgical Ethics Edited by Laurence B. McCullough, James W. Jones, and Baruch A. Brody. 396 pp. New York, Oxford University Press, 1998. $49.50. 0-19-510347-5 (1999) (0)
MP40-01 HEDGEHOG PATHWAY BIOMARKERS PREDICT ONCOLOGIC OUTCOME IN CLEAR CELL RENAL CELL CARCINOMA (2014) (0)
MP59-16 RENAL ARTERY PSEUDOANEURYSMS AFTER NEPHRON SPARING SURGERY FOR RENAL CELL CARCINOMA: INCIDENCE, MANAGEMENT AND FUNCTIONAL OUTCOMES FROM CANADIAN KIDNEY CANCER INFORMATION SYSTEM DATABASE. (2014) (0)
Phase I I T rial o f t he A ntiangiogenic A gent T halidomide i n Patients W ith R ecurrent H igh-Grade G liomas (2000) (0)

This paper list is powered by the following services:

What Schools Are Affiliated With Peter Mcl. Black?

Peter Mcl. Black is affiliated with the following schools:

Peter Mcl. Black's Academic­Influence.com Rankings